Reports for SANDOZ CANADA INCORPORATED
Company Name
SANDOZ CANADA INCORPORATED
Totals |
||
Shortage reports |
2266 |
|
| Actual shortage: | 50 (2%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 19 (1%) | |
| Resolved: | 2197 (97%) | |
Discontinuation Reports |
124 |
|
| To be discontinued: | 4 (3%) | |
| Discontinued: | 118 (95%) | |
| Reversed: | 2 (2%) | |
Late reports |
451 (19%) |
|
Overdue reports |
11 (20%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| GLYCOPYRROLATE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2022-02-08 | 2022-03-15 | 154523 |
| GLYCOPYRROLATE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2022-08-18 | 2022-11-29 | 167366 |
| GLYCOPYRROLATE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2022-08-18 | 2022-11-29 | 167369 |
| GLYCOPYRROLATE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2023-03-03 | 2023-04-05 | 186160 |
| GLYCOPYRROLATE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2023-09-11 | 2023-10-11 | 204118 |
| GLYCOPYRROLATE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2023-11-13 | 2023-12-05 | 210061 |
| HALOPERIDOL INJ 5MG/ML USP | 5MG | LIQUID | Resolved | 2022-10-04 | 2022-10-20 | 171063 |
| HALOPERIDOL INJ 5MG/ML USP | 5MG | LIQUID | Resolved | 2022-11-16 | 2022-11-17 | 174901 |
| HALOPERIDOL INJ 5MG/ML USP | 5MG | LIQUID | Resolved | 2022-12-12 | 2023-02-01 | 177931 |
| HALOPERIDOL INJ 5MG/ML USP | 5MG | LIQUID | Resolved | 2023-03-03 | 2023-03-14 | 186163 |
| HALOPERIDOL LA | 100MG | LIQUID | Resolved | 2018-07-30 | 2018-12-17 | 56881 |
| HALOPERIDOL LA | 100MG | LIQUID | Resolved | 2018-09-30 | 2018-10-04 | 62723 |
| HALOPERIDOL LA | 100MG | LIQUID | Resolved | 2021-06-14 | 2021-08-03 | 140850 |
| HALOPERIDOL LA | 100MG | LIQUID | Resolved | 2022-04-20 | 2022-09-02 | 159048 |
| HALOPERIDOL LA | 100MG | LIQUID | Resolved | 2022-11-16 | 2022-12-29 | 174904 |
| HALOPERIDOL LA | 100MG | LIQUID | Resolved | 2023-12-19 | 2024-01-17 | 213813 |
| HALOPERIDOL LA | 100MG | LIQUID | Resolved | 2025-08-15 | 2025-09-13 | 265318 |
| HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) | 1000UNIT | SOLUTION | Resolved | 2021-01-18 | 2021-02-01 | 131827 |
| HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) | 1000UNIT | SOLUTION | Resolved | 2021-07-05 | 2022-08-18 | 141775 |
| HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) | 1000UNIT | SOLUTION | Resolved | 2022-09-01 | 2022-09-28 | 168474 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TOBRAMYCIN INHALATION SOLUTION | 300MG | SOLUTION | Discontinued | 2021-09-02 | 2021-09-02 | 145015 |
| VITAMIN B12 | 100MCG | LIQUID | Discontinued | 2017-06-06 | 2017-07-01 | 12133 |
| ZOFRAN ODT | 8MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2022-12-08 | 2023-03-14 | 177540 |
| ZOFRAN ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2023-03-14 | 2023-03-14 | 187062 |